The Seattle Structural Genomics Center for Infectious Disease (SSGCID) announced Monday that it and its sister research group will receive up to $48.4 million in renewed funding from the National Institutes of Health, spread out over the next five years. The two groups research treatments and preventions for deadly diseases, aided with next-generation genomic modeling of the pathogens and their related proteins. SSGCID is a Washington consortium led by Center for Infectious Disease Research professor Peter Myler. The second group, the Center for Structural Genomics of Infectious Diseases (CSGID), is a consortium of research groups led by Karla Satchell of Northwestern University.
News Brief
